The NAD precursor supplements market is projected to be valued at USD 876.2 million in 2025 and is anticipated to reach USD 1,581.1 million by 2035. Healthy aging and longevity leads the health function with a share of 38% in 2025. Capsules remains the preferred product format with 40% share in 2025.